VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,735,696 | +130.6% | 64,500 | +158.0% | 0.01% | +40.0% |
| Q2 2023 | $752,750 | +5.1% | 25,000 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $716,500 | -40.6% | 25,000 | -50.0% | 0.01% | -36.4% |
| Q3 2022 | $1,206,000 | +46.9% | 50,000 | +66.7% | 0.01% | +83.3% |
| Q2 2022 | $821,000 | -27.6% | 30,000 | -44.2% | 0.01% | -60.0% |
| Q4 2018 | $1,134,000 | -42.1% | 53,750 | -49.2% | 0.02% | -37.5% |
| Q3 2018 | $1,958,000 | +10.5% | 105,750 | +36.1% | 0.02% | 0.0% |
| Q1 2017 | $1,772,000 | +34.4% | 77,680 | +23.3% | 0.02% | +71.4% |
| Q4 2016 | $1,318,000 | +30.4% | 63,000 | +72.6% | 0.01% | -54.8% |
| Q2 2016 | $1,011,000 | – | 36,510 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |